查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014298

石膏和夹板市场：按产品类型、材料、最终用户和应用划分 - 2026-2032年全球市场预测

Casting & Splinting Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，石膏和夹板市场价值将达到 27.5 亿美元，到 2026 年将成长到 29.4 亿美元，到 2032 年将达到 48 亿美元，年复合成长率为 8.25%。

主要市场统计数据
基准年 2025 27.5亿美元
预计年份：2026年 29.4亿美元
预测年份 2032 48亿美元
复合年增长率 (%) 8.25%

为了促进循证决策，我们对影响石膏和夹板固定的临床、营运和供应链趋势进行了简洁且权威的概述。

石膏和夹板仍然是整形外科、创伤护理和復健医学中基本的治疗方法。这些治疗方法与临床结果、医疗设备设计和供应链趋势密切相关，并随着新材料、製造方法和医疗服务模式的出现，以及临床医生偏好和患者期望的变化而不断发展。医疗专业人员寻求兼顾固定效果、重量、渗透性、透光性和易用性的解决方案，而医疗系统则要求器械能够缩短手术时间并最大限度地减少术后併发症。

临床重点、材料创新、医疗保健分散化和监管期望如何共同重新定义石膏和夹板固定领域的产品和营运策略。

在石膏和夹板领域，多种因素共同推动变革。临床上，人们正逐渐倾向于选择能够更快应用、提高患者舒适度并更好地与影像学检查相容的解决方案。这一趋势促使人们关注合成材料和热塑性材料，与传统石膏相比，它们具有更优异的渗透性和更轻的重量。同时，临床医生在选择固定策略时也更加重视在临床适宜的情况下儘早允许患者活动，这影响着产品的选择和復健后护理路径。

对 2025 年关税政策变化将如何改变石膏和夹板供应链中的筹资策略、成本结构和製造决策进行基于证据的评估。

2025年实施的最新关税措施对石膏和夹板的价值链产生了多方面的影响。对某些聚合物组件和成品医疗设备征收的进口关税增加了部分製造商和经销商的收货成本，促使他们迅速重新检视筹资策略。对于依赖海外供应商提供热塑性树脂、玻璃纤维布和特殊黏合剂的企业而言，这些影响既体现在营运层面，也体现在财务层面。采购团队已审查了与供应商的合同，合併订单以实现规模经济，并探索替代运输和海关清关方案，以最大限度地减少中断。

透过对产品类型、材料、医疗保健环境和临床应用进行实际细分，可以指导优先产品组合开发和商业化。

产品类型的差异化会影响产品的采用趋势和研发重点。玻璃纤维石膏在强度和重量之间取得了极佳的平衡，而石膏在低成本和可塑性至关重要的场合仍然非常实用。夹板，包括动态夹板和静态夹板，越来越多地用于有针对性的固定和復健。合成石膏在特定的临床场景中提供了快速固化、防水的选择，而热塑性石膏则具有可自订的形状和更高的舒适度。由于每个产品类型都与特定的临床工作流程和培训需求相关，产品组合经理必须使其开发平臺与最快采用这些产品的服务线保持一致。

对当地医疗保健系统、采购惯例和物流现实如何决定产品采用、生产在地化和市场进入策略进行比较分析。

区域差异对产品偏好、监管通路和分销模式有显着影响。美洲地区呈现异质性环境，三级医院系统和门诊医疗机构的临床实务模式各不相同。在采购决策中，服务整合、品质保证以及与经销商的合约关係往往备受重视。在该地区，人们越来越关注能够支援快速更换和门诊管理的合成材料和热塑性材料，而在资源有限的环境中，传统石膏的使用仍然普遍。

产品创新、临床伙伴关係、製造多元化和价值主导定位如何决定石膏和夹板製造商的竞争优势。

石膏和夹板行业的主要企业正致力于产品创新、临床教育和分销优化三者相结合。新型材料配方和预製夹板设计体现了以用户为中心的理念，即减轻重量、提高透气性以及与影像技术的兼容性。医疗设备製造商与临床网路之间的策略合作正在加速推进，重点在于开展培训项目，以缩短临床医生的学习曲线并加快应用速度。

针对製造商、经销商和医疗保健提供者的具体策略措施，以增强营运稳健性、临床应用和以价值为导向的商业性成果。

我们将优先发展模组化产品线，使临床医生能够根据特定临床路径选择最合适的材料和应用方案，从而加快采购核准并简化库存管理。我们将投资于临床医生培训项目，重点关注应用效率、患者舒适度和基于疗效的应用案例，以缩短引进週期并降低应用品质的差异性。改进的品质文件和简化的监管申报流程将有助于进入多元化的区域市场，并缩短改良材料的上市时间。

我们高度透明、以实践者为主导的调查方法，结合了对临床医生的访谈、技术文献和供应链指标，提供了可操作的见解和检验。

本分析整合了第一手和第二手调查数据，以得出以医疗保健专业人员观点的全面评估。第一手资讯包括对急诊、门诊和居家照护机构的临床医生进行结构化访谈，以了解他们在临床实践中的使用偏好、采购决策因素以及培训不足的领域。第二手调查则纳入了关于材料性能的技术文献和监管指南，以检验临床声明并促进对产品特性的比较评估。

整合临床趋势、供应链实际状况和竞争需求，指导石膏和夹板领域的投资、产品策略和营运决策。

石膏和夹板产业正处于转折点，材料科学、临床工作流程的变革以及贸易政策趋势的交汇融合，重塑着产业的策略选择。临床医生和采购经理必须权衡传统技术与创新技术，后者可望提升病患体验和营运效率，同时也要应对日益复杂的供应链环境。那些能够整合临床医生培训、实现供应链多元化并为医疗系统创造实际价值的公司，将更有能力影响采购决策并保持成长。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：石膏与夹板市场：依产品类型划分

  • 玻璃纤维铸件
  • 石膏模型
  • 夹板
    • 动态夹板
    • 静态夹板
  • 合成铸件
  • 热塑性铸件

第九章：石膏和夹板市场：依材料分类

  • 玻璃纤维
  • 石膏
  • 热塑性树脂
    • 用于高温的热塑性树脂
    • 低温热塑性树脂

第十章：石膏和夹板市场：按最终用户划分

  • 门诊手术中心
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院
  • 整形外科诊所

第十一章：石膏与夹板市场：依应用领域划分

  • 正畸模型
  • 断裂
    • 下肢骨折
    • 上肢骨折
  • 术后固定

第十二章：石膏绷带和夹板市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：石膏与夹板市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：石膏模型与夹板市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国石膏与夹板市场

第十六章：中国石膏与夹板市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • AliMed, Inc.
  • Bird & Cronin, Inc.
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Corflex, Inc.
  • DeRoyal Industries, Inc.
  • DJO Global, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, LP
  • Prime Medical, Inc.
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf.
Product Code: MRR-433AB1DC28B4

The Casting & Splinting Market was valued at USD 2.75 billion in 2025 and is projected to grow to USD 2.94 billion in 2026, with a CAGR of 8.25%, reaching USD 4.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.75 billion
Estimated Year [2026] USD 2.94 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 8.25%

A concise, authoritative framing of clinical, operational, and supply-chain dynamics shaping casting and splinting for evidence-driven decision-making

Casting and splinting remain foundational interventions across orthopedics, trauma care, and rehabilitative medicine. These modalities intersect clinical outcomes, device design, and supply-chain dynamics, and they continue to evolve as new materials, fabrication methods, and care-delivery models alter clinician preferences and patient expectations. Practitioners demand solutions that balance immobilization efficacy with weight, comfort, radiolucency, and ease of application, while health systems seek devices that reduce procedure time and downstream complications.

As pressure mounts on procurement, reimbursement, and operating margins, manufacturers and clinical leaders must coordinate on product innovation, training, and inventory strategies. Technological advances in thermoplastics and synthetic casting systems have introduced alternative application techniques and new sterilization considerations, prompting a reassessment of clinical protocols. Concurrently, ambulatory surgical centers and home healthcare providers are expanding their role in fracture management and postoperative immobilization, necessitating products optimized for decentralized settings.

This introduction sets the stage for a deeper analysis of transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive activity, and practical recommendations for leaders who must act decisively to maintain clinical relevance and operational resilience in a changing environment.

How clinical priorities, materials innovation, decentralization of care, and regulatory expectations are jointly redefining product and operational strategy in casting and splinting

The casting and splinting landscape is experiencing several converging forces that drive transformation. Clinically, there is a steady migration toward solutions that enable faster application, improved patient comfort, and enhanced imaging compatibility. This trend has increased interest in synthetic and thermoplastic options that offer superior radiolucency and weight reduction compared with traditional plaster. At the same time, clinicians are more selective about immobilization strategies that permit early mobility when clinically appropriate, which affects product selection and post-acute care pathways.

From a manufacturing perspective, materials science innovation has accelerated, with higher-performance thermoplastics and resin systems enabling lighter, more durable constructs and new prefabricated splint designs. Additive manufacturing and digital fitting workflows are beginning to influence custom orthoses and splinting solutions, offering shorter lead times and improved patient fit. These advances challenge legacy supply models and necessitate closer integration between design engineers, clinical educators, and procurement teams.

On the systems side, healthcare delivery is decentralizing; ambulatory surgical centers and home-based care providers are handling a larger share of fracture care and postoperative immobilization, requiring products that simplify training and inventory management. Regulatory emphasis on safety, sterilization, and traceability has intensified, prompting manufacturers to strengthen quality systems and labeling clarity. Taken together, these shifts demand a strategic response from product developers, hospital systems, and distributors to ensure alignment with new clinical workflows and economic pressures.

An evidence-based appraisal of how 2025 tariff policy changes have redirected sourcing strategies, cost structures, and manufacturing decisions in the casting and splinting supply chain

Recent tariff actions in 2025 have had a multifaceted effect on the casting and splinting value chain. Import levies on select polymer components and finished medical devices have raised landed costs for some manufacturers and distributors, prompting rapid reassessment of sourcing strategies. For organizations reliant on overseas suppliers of thermoplastic resins, fiberglass fabrics, and specialized adhesives, the impact has been both operational and financial: procurement teams have revisited supplier contracts, consolidated orders to achieve scale, and explored alternative freight and customs optimization tactics to minimize disruption.

The tariffs have also catalyzed investment decisions. Some manufacturers accelerated plans to localize production or qualify domestic resin and fabric suppliers to reduce exposure to cross-border duties and to improve lead-time reliability. This shift toward nearshoring has implications for capacity planning, capital allocation, and workforce development, as production processes and quality systems are adapted to local regulatory expectations. At the same time, smaller suppliers faced pressure to renegotiate terms or pass cost increases downstream, influencing distributor inventory strategies and clinical purchasing decisions.

Clinicians and hospital procurement leaders responded by emphasizing product standardization and bilateral contracts that lock pricing or provide hedging mechanisms. Payers and health systems scrutinized total cost of care implications, focusing on devices that support reduced length of stay and fewer complications rather than strictly low unit price. Ultimately, the tariffs reinforced the need for supply-chain transparency, material substitution assessments, and scenario planning to preserve service levels and clinical outcomes in an environment of shifting trade policy.

Actionable segmentation insights across product types, materials, care settings, and clinical applications to guide prioritized portfolio development and commercialization

Differentiation across product type influences adoption dynamics and development priorities. Fiberglass casts offer a balance of strength and weight, plaster casts remain relevant where low cost and malleability are paramount, splints-comprising dynamic splints and static splints-are increasingly used for targeted immobilization and rehabilitation, synthetic casts provide rapid-setting, water-resistant alternatives for select clinical scenarios, and thermoplastic casts deliver customizable profiles and improved comfort. Each product category aligns with specific clinical workflows and training needs, so portfolio managers must align development pipelines with the service lines that will adopt them most rapidly.

Material choice shapes manufacturing processes and clinical performance. Fiberglass materials are prized for their tensile strength and radiolucency, plaster of Paris continues to be used where conformability and cost are deciding factors, and thermoplastics-with subdivisions into high temperature and low temperature thermoplastics-enable custom-molding and reusability considerations. The properties of high temperature thermoplastics support durable, semi-permanent orthoses, while low temperature thermoplastics offer convenience for in-clinic molding, influencing decisions about inventory and clinician training.

End-user segmentation reveals divergent procurement behaviors and use cases. Ambulatory surgical centers prioritize speed and predictable device costs as they manage high-throughput procedures. Home healthcare providers emphasize lightweight, patient-friendly solutions that facilitate in-home care and reduce caregiver burden. Hospitals, which include private and public institutions, balance clinical efficacy with infection control and supply-chain resilience. Orthopedic clinics concentrate on specialized splinting options that support outpatient rehabilitation protocols. Recognizing these differences informs sales approaches, training programs, and product configuration choices.

Application-focused segmentation clarifies clinical demand drivers. Corrective casting requires materials and designs that support anatomical conformity and prolonged wear, fractures demand variable immobilization strategies depending on lower limb fractures or upper limb fractures, and postoperative immobilization stresses comfort, wound access, and compatibility with imaging. Understanding the nuances of each application enables manufacturers and providers to prioritize product attributes such as weight, breathability, adjustability, and radiolucency to maximize clinical fit and operational adoption.

A comparative view of how regional healthcare structures, procurement practices, and logistics realities determine product adoption, manufacturing localization, and go-to-market strategies

Regional differences materially influence product preference, regulatory pathways, and distribution models. The Americas present a heterogeneous environment where clinical practice patterns vary between tertiary hospital systems and ambulatory providers; procurement decisions often emphasize service integration, quality assurance, and contractual relationships with distributors. This region shows rising interest in synthetic and thermoplastic options that support rapid turnover and outpatient management, while also maintaining legacy plaster use in resource-constrained settings.

Europe, Middle East & Africa exhibit a complex mosaic of regulatory regimes and reimbursement structures that affect device uptake and clinical training investments. In some jurisdictions, centralized procurement encourages standardized solutions that simplify inventory management, whereas other jurisdictions place greater emphasis on clinician discretion and bespoke orthotic services. Economic diversity within the region drives both innovation opportunities and affordability pressures, so manufacturers must tailor commercialization strategies and regulatory support accordingly.

Asia-Pacific demonstrates varied adoption trajectories driven by demographic shifts, urbanization, and differential investment in surgical and rehabilitative care. Rapidly developing healthcare markets are primed for technologies that streamline care delivery and lower long-term costs, while established systems emphasize evidence-based selection and integration with electronic health records. Across these regions, supply-chain resilience and localization strategies have become central planning priorities due to trade policy shifts and logistics constraints, prompting region-specific manufacturing and distribution decisions to mitigate risk and support steady product availability.

How product innovation, clinical partnerships, manufacturing diversification, and value-driven positioning are defining competitive advantage for casting and splinting companies

Leading companies in casting and splinting are pursuing a combination of product innovation, clinical education, and distribution optimization. New material formulations and prefabricated splint designs reflect an emphasis on user-centered outcomes-lighter constructs, improved breathability, and compatibility with imaging modalities. Strategic partnerships between device firms and clinical networks have accelerated by focusing on training programs that shorten clinician learning curves and demonstrate time-savings in application.

Collaboration extends to supply-chain partnerships and contract manufacturing relationships that secure raw materials and flexible capacity. Firms that proactively diversified their supplier base or invested in regional manufacturing capacity reduced exposure to trade policy volatility and improved service levels. Meanwhile, companies enhancing digital tools for product selection, fitting support, and telehealth integration created differentiated value propositions for ambulatory and home-care settings. These integrated offerings strengthen distributor relationships and provide clinicians with decision-support resources that shorten procurement cycles.

Competitive positioning increasingly reflects a balance between commoditized offerings and higher-margin specialty products. Organizations that maintain strong clinical evidence, robust training, and responsive technical support tend to secure preferred-provider status within hospital systems and outpatient networks. As reimbursement models emphasize value and outcomes, companies that can demonstrate device contributions to lower complication rates, reduced readmissions, or shorter recovery timelines will maintain a distinct advantage in contracting conversations.

Concrete strategic moves for manufacturers, distributors, and providers to boost operational robustness, clinical uptake, and value-aligned commercial outcomes

Prioritize modular product families that allow clinicians to choose materials and application profiles suited to specific clinical pathways, enabling faster procurement approvals and streamlined inventory management. Invest in clinician-focused education programs that emphasize application efficiency, patient comfort, and outcomes-based use cases to shorten adoption cycles and reduce variability in application quality. Strengthening quality documentation and simplifying regulatory submissions will ease entry into diverse regional markets and reduce time-to-market for upgraded materials.

Develop supply-chain playbooks that include dual sourcing, nearshoring feasibility studies, and contract terms that mitigate tariff exposure. These measures reduce vulnerability to trade-policy shifts and logistics disruptions. Simultaneously, build commercial models that align pricing with clinical value rather than unit cost alone, demonstrating how device selection can reduce total care episodes, complications, or follow-up interventions. Finally, expand digital enablement tools-fitting guides, telehealth support, and post-application monitoring-to improve patient satisfaction and support longitudinal evidence generation that bolsters reimbursement conversations.

A transparent, practitioner-informed methodology integrating clinician interviews, technical literature, and supply-chain indicators to underpin actionable insights and validation

This analysis synthesizes primary and secondary inputs to produce a rounded, practitioner-focused assessment. Primary inputs included structured interviews with clinicians across acute, ambulatory, and home-care settings to capture real-world application preferences, procurement decision drivers, and training gaps. Secondary research incorporated technical literature on materials performance and regulatory guidance to validate clinical claims and to inform comparative assessments of product attributes.

Triangulation methods were applied to reconcile stakeholder perspectives with observable supply-chain indicators, such as supplier diversification trends, regional manufacturing announcements, and public policy changes affecting trade. Expert validation sessions ensured that emerging themes-material substitution, decentralization of care, and tariff-driven nearshoring-were robust against alternate interpretations. The resulting synthesis emphasizes actionable takeaways and practical frameworks for leaders considering investment, product development, or procurement changes.

A synthesis of clinical trends, supply-chain realities, and competitive imperatives to guide investment, product strategy, and operational decision-making in casting and splinting

The casting and splinting domain is at an inflection point where material science, clinical workflow changes, and trade-policy developments collectively reshape strategic choices. Clinicians and procurement leaders must weigh traditional techniques against innovations that promise better patient experience and operational efficiency, all while navigating a more complex supply environment. Companies that integrate clinician education, diversify supply chains, and deliver demonstrable value to health systems will be best positioned to influence purchasing decisions and sustain growth.

Moving forward, stakeholders should prioritize evidence generation, flexible manufacturing strategies, and customer-centric commercialization that addresses the needs of hospitals, ambulatory centers, home healthcare providers, and specialty clinics. By aligning product development with end-user workflows and regional logistics realities, organizations can reduce risk, accelerate adoption, and ensure that casting and splinting innovations translate into meaningful clinical and operational benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Casting & Splinting Market, by Product Type

  • 8.1. Fiberglass Casts
  • 8.2. Plaster Casts
  • 8.3. Splints
    • 8.3.1. Dynamic Splints
    • 8.3.2. Static Splints
  • 8.4. Synthetic Casts
  • 8.5. Thermoplastic Casts

9. Casting & Splinting Market, by Material

  • 9.1. Fiberglass
  • 9.2. Plaster Of Paris
  • 9.3. Thermoplastics
    • 9.3.1. High Temperature Thermoplastics
    • 9.3.2. Low Temperature Thermoplastics

10. Casting & Splinting Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Orthopedic Clinics

11. Casting & Splinting Market, by Application

  • 11.1. Corrective Casting
  • 11.2. Fractures
    • 11.2.1. Lower Limb Fractures
    • 11.2.2. Upper Limb Fractures
  • 11.3. Post Operative Immobilization

12. Casting & Splinting Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Casting & Splinting Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Casting & Splinting Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Casting & Splinting Market

16. China Casting & Splinting Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. AliMed, Inc.
  • 17.7. Bird & Cronin, Inc.
  • 17.8. BSN Medical GmbH
  • 17.9. Cardinal Health, Inc.
  • 17.10. Corflex, Inc.
  • 17.11. DeRoyal Industries, Inc.
  • 17.12. DJO Global, Inc.
  • 17.13. Johnson & Johnson
  • 17.14. McKesson Corporation
  • 17.15. Medline Industries, LP
  • 17.16. Prime Medical, Inc.
  • 17.17. Smith & Nephew plc
  • 17.18. Zimmer Biomet Holdings, Inc.
  • 17.19. Ossur hf.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CASTING & SPLINTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CASTING & SPLINTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2032 (USD MILLION)